Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients

Clinical trial NCT06388642 · COMPLETED

Trial details

NCT number: NCT06388642
Sponsor: Clinuvel Europe Limited
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Erythropoietic Protoporphyria

Start date: 2024-03-07
Primary completion: 2024-10-28
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.